🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Melanoma, Stage II

An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors NCT07371663Phase 1, Phase 23 sites📍 Beijing📍 Zhengzhou📍 Hangzhou Beijing Tide Pharmaceutical Co., Ltd · Tests: TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg, benmelstobart Injection A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab NCT02621021Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: young TIL, Pembrolizumab, Aldesleukin, Fludarabine, Cyclophosphamide Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma NCT03860883NA192 sites📍 Mobile📍 Gilbert📍 Phoenix Melanoma and Skin Cancer Trials Limited · Tests: Wide Local Excision = 1cm Margin, Wide Local Excision = 2cm Margin Tebentafusp-tebn With LDT in Metastatic UM NCT06626516Phase 1, Phase 21 site📍 Philadelphia Thomas Jefferson University · Tests: Tebentafusp-Tebn, GM-CSF (Sargramostim), BCNU Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma NCT07136181Phase 1, Phase 23 sites📍 Scottsdale📍 Denver📍 Nashville Novelwise Pharmaceutical Corporation · Tests: NBM-BMX Capsule are proprietary products developed by Novelwise Pharmaceutical Corporation (Novelwise) for treatment of… Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC NCT07718243Phase 1, Phase 22 sites📍 Manchester📍 Sutton Institute of Cancer Research, United Kingdom · Tests: Bexmarilimab 1mg/kg and nivolumab 1mg/kg, Bexmarilimab 3mg/kg and nivolumab 1mg/kg, Recommended Phase II Dose Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma NCT04598009Phase 22 sites📍 La Jolla📍 San Francisco University of California, San Francisco · Tests: Binimetinib, Imatinib Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma NCT04697576Phase 11 site📍 Columbus Carlo Contreras · Tests: Ipilimumab, Nivolumab, Pembrolizumab, Quadrivalent Inactivated Influenza Vaccine, Resection A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors NCT07115043Phase 1, Phase 213 sites📍 Grand Rapids📍 St Louis📍 Pittsburgh AstraZeneca · Tests: AZD6750, rilvegostomig Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial NCT07155317Phase 22 sites📍 Atlanta📍 Atlanta Emory University · Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Ipilimumab, Magnetic Resonance Imaging Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma NCT07476326Phase 146 sites📍 Bento Gonçalves📍 Ijuí📍 Pará Biocon Biologics UK PLC · Tests: Bmab1700, Opdivo Skin Cancer and Hyperthermia and Radiotherapy NCT06384053NA4 sites📍 Aarau📍 Winterthur📍 Bern Kantonsspital Winterthur KSW · Tests: Water-filtered infrared-A-hyperthermia (wIRA) hyperthermia combined, Radiotherapy (RT) A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors NCT07070232Phase 1, Phase 277 sites📍 Phoenix📍 San Francisco📍 Hartford BioNTech SE · Tests: BNT326, Pumitamig, Itraconazole, Paroxetine Axelopran and Nivolumab in PD-1-Refractory Metastatic Melanoma NCT07631325Phase 1, Phase 21 site📍 Pittsburgh John Kirkwood · Tests: Axelopran, Nivolumab Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases NCT05704647Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: BMS-986213 (Relatlimab-Nivolumab FDC), Nivolumab, Relatlimab GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors NCT06265025Phase 1, Phase 24 sites📍 Goyang-si📍 Seoul📍 Seoul GeneMedicine Co., Ltd. · Tests: GM103 (Part A), GM103 (Part B), GM103 and Pembrolizumab (Part C) Neoadjuvant Tebentafusp for Uveal Melanoma NCT06414590Phase 22 sites📍 Philadelphia📍 Philadelphia Thomas Jefferson University · Tests: Tebentafusp-Tebn AMT-253 in Patients With Advanced Solid Tumours NCT06209580Phase 1, Phase 21 site📍 Beijing Multitude Therapeutics Inc. · Tests: AMT-253 for injection LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma NCT06623461Phase 215 sites📍 Abbotsford British Columbia📍 Surrey📍 Vancouver Canadian Cancer Trials Group · Tests: Standard of Care Immune Checkpoint Blockade, LND101 Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi NCT06599619n/a1 site📍 Pittsburgh John Kirkwood · Tests: Single agent, adjuvant anti-PD1 therapy Cryoablation Combined With Hepatic Arterial Infusion of Iparomlimab and Tuvonralimab (QL1706), Intravenous Dacarbazine, and Oral Lenvatinib in Patients With Liver Metastases From Malignant Melanoma: a Single-arm, Phase II, Prospective Trial NCT07847359Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Cryoablation, Iparomlimab and Tuvonralimab, Dacarbazine, Lenvatinib Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases NCT06712927Phase 21 site📍 Palo Alto Stanford University · Tests: Ipilimumab, Nivolumab + Relatlimab FDC A Study of BL-M08D in Patients With Locally Advanced or Metastatic Melanoma and Other Solid Tumors NCT07841925Phase 1, Phase 21 site📍 Beijing Sichuan Baili Pharmaceutical Co., Ltd. · Tests: BL-M08D1 A Study of IBI363 in Subjects With Advanced Melanoma NCT06081920Phase 212 sites📍 Beijing📍 Beijing📍 Fuzhou Innovent Biologics (Suzhou) Co. Ltd. · Tests: IBI363 A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information NCT07621614Phase 213 sites📍 Oakland📍 Wilmington📍 Jacksonville Children's Oncology Group · Tests: Biospecimen Collection, Chest Radiography, Computed Tomography, Fludeoxyglucose F-18, Magnetic Resonance Imaging Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain NCT05588453Phase 1, Phase 21 site📍 Columbus Kari Kendra · Tests: Natural Killer Cell Therapy, Temozolomide Stereotactic Ablative Radiotherapy (XRT) and Immunotherapy for Oligometastatic Extracranial Melanoma NCT06767306Phase 25 sites📍 Westmead📍 Wollstonecraft📍 Woolloongabba Melanoma Institute Australia · Tests: Stereotactic Body Radiotherapy (extracranial) concurrent with Immunotherapy, Immunotherapy alone Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program NCT06265285Phase 21 site📍 Jacksonville Mayo Clinic · Tests: Home Health Encounter, Nivolumab, Patient Monitoring, Questionnaire Administration A Phase II Clinical Trial on Neo-adjuvant Pembrolizumab in Patients With pT3b-T4a/b cN0M0 Melanoma. NCT07448831Phase 21 site📍 Jette Universitair Ziekenhuis Brussel · Tests: Pembrolizumab Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study) NCT03340129Phase 29 sites📍 Sydney📍 Waratah📍 Wollstonecraft Melanoma Institute Australia · Tests: Ipilimumab, Nivolumab, Stereotactic Radiotherapy, Salvage therapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy